Loading
A phase 3 trial in colorectal cancer, run by University Hospital, Rouen, now recruiting.
Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy is a phase 3, randomised interventional study registered as NCT06107920 by University Hospital, Rouen, with a registry enrolment figure of 232 participants, started 2024-05-07 and due to reach its primary completion in 2031-08. Interventions recorded: Neoadjuvant chemotherapy. Conditions listed: Colon Cancer. Primary outcome: the success of a full curative therapeutic. Colorectal eligibility wording from the registry: "* Patients with obstructive colon cancer treated by defunctioning stoma". Sites: France. No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.